Table 2.
Multivariate logistic regression analysis of risk of in-hospital mortality in patients with AMI after propensity score matching
| β | OR | 95% CI | P-value | |
|---|---|---|---|---|
| NLR grouping | 1.497 | 4.469 | 2.069-9.653 | < 0.001 |
| PLR grouping | 0.879 | 2.410 | 1.155-5.029 | 0.019 |
| BMI | -0.063 | 0.939 | 0.855-1.032 | 0.189 |
| SBP | -0.004 | 0.996 | 0.984-1.009 | 0.582 |
| AST | 0.002 | 1.002 | 0.999-1.005 | 0.150 |
| CKMB | -0.004 | 0.996 | 0.991-1.000 | 0.049 |
| LDL-C | -0.083 | 0.920 | 0.643-1.317 | 0.649 |
| Aspirin use | 0.149 | 1.160 | 0.397-3.393 | 0.786 |
| Statins use | -1.251 | 0.286 | 0.038-2.177 | 0.227 |
Note: NLR grouping (NLR ≤ 5.094 = 0; NLR > 165.413 = 1, NLR ≤ 5.094 as reference); PLR grouping (PLR ≤ 165.413 = 0; PLR > 165.413 = 1, PLR ≤ 165.413 as reference). NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; BMI, body mass index; SBP, systolic blood press; AST, aspartate aminotransferase; CK-MB, creatine kinase-MB; LDL-C, low-density lipoprotein cholesterol.